Valeant (VRX) May Tuck Tail if Obagi (OMPI) Bidding War Heats Up - Analyst
Tweet Send to a Friend
Yesterday Valeant Pharmaceuticals (NYSE: VRX) raised its offer for Obagi Medical Products, Inc. (NASDAQ: OMPI) from $19.75 to $24 per ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
